coronary heart disease
Conditions
Interventions
the intervention group:intelligent pharmaceutical services
the control group:conventional pharmaceutical services
Sponsors
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Aged < 85 years, gender is not limited; 2. Patients with admission diagnosis who meet the diagnostic criteria of coronary heart disease and who have successfully performed PCI; 3. Normal thinking, with normal language communication and reading ability, able to clearly understand and answer the questions raised; 4. Have a personal mobile phone with an exact phone number; 5. Participants voluntarily participated in the clinical trial and signed the informed consent form, and were willing to participate in postoperative follow-up.
Exclusion criteria
Exclusion criteria: 1. Severe heart, liver, kidney, brain, mental, neurological disorders, affecting informed consent and/or affecting expression or observation; 2. Patients with hearing impairment and visual impairment; 3. Stent surgery for coronary heart disease is required after discharge; 4. The researcher believes that it is not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| medication adherence; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of cardiovascular adverse events;incidence of adverse drug reactions;incidence of return visits;participants' knowledge of CHD;the percentage of people who stick to healthy living;acceptability of interventions and the satisfaction of patients; | — |
Countries
China
Contacts
Public ContactTong Huangjin
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed